单位:[1]Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China重庆医科大学附属第一医院[2]Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing 402160, Peoples R China[3]Chongqing Med Univ, First Affiliated 1, Dept Neurosurg, Chongqing 400016, Peoples R China[4]Guizhou Med Univ, Emergency Dept, Affiliated Hosp, Guiyang 550025, Peoples R China[5]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Neurol,Wuhan 430030,Hubei,Peoples R China神经内科华中科技大学同济医学院附属同济医院神经科[6]Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing 400016, Peoples R China重庆医科大学附属第一医院[7]Harvard Med Sch, Massachusetts Gen Hosp, Div Neurocrit Care & Emergency Neurol, Boston, MA 02114 USA
Background/Objectives The objective of this study is to propose a definition of intraventricular hemorrhage (IVH) growth and to investigate whether IVH growth is associated with ICH expansion and functional outcome. Methods We performed a prospective observational study of ICH patients between July 2011 and March 2017 in a tertiary hospital. Patients were included if they had a baseline CT scan within 6 h after onset of symptoms and a follow-up CT within 36 h. IVH growth was defined as either any newly occurring intraventricular bleeding on follow-up CT scan in patients without baseline IVH or an increase in IVH volume >= 1 mL on follow-up CT scan in patients with initial IVH. Poor outcome was defined as modified Rankin Scale score of 3-6 at 90 days. The association between IVH growth and functional outcome was assessed by using multivariable logistic regression analysis. Results IVH growth was observed in 59 (19.5%) of 303 patients. Patients with IVH growth had larger baseline hematoma volume, higher NIHSS score and lower GCS score than those without. Of 44 patients who had concurrent IVH growth and hematoma growth, 41 (93.2%) had poor functional outcome at 3-month follow-up. IVH growth (adjusted OR 4.15, 95% CI 1.31-13.20; P = 0.016) was an independent predictor of poor functional outcome (mRS 3-6) at 3 months in multivariable analysis. Conclusion IVH growth is not uncommon and independently predicts poor outcome in ICH patients. It may serve as a promising therapeutic target for intervention.
基金:
National Key R&D Program of China [2018YFC1312200, 2018YFC1312203]; Chongqing High-end Young Investigator Project [2019GDRC005]
第一作者单位:[1]Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Li Qi,Li Rui,Zhao Li-Bo,et al.Intraventricular Hemorrhage Growth: Definition, Prevalence and Association with Hematoma Expansion and Prognosis[J].NEUROCRITICAL CARE.2020,33(3):732-739.doi:10.1007/s12028-020-00958-8.
APA:
Li, Qi,Li, Rui,Zhao, Li-Bo,Yang, Xiao-Min,Yang, Wen-Song...&Xie, Peng.(2020).Intraventricular Hemorrhage Growth: Definition, Prevalence and Association with Hematoma Expansion and Prognosis.NEUROCRITICAL CARE,33,(3)
MLA:
Li, Qi,et al."Intraventricular Hemorrhage Growth: Definition, Prevalence and Association with Hematoma Expansion and Prognosis".NEUROCRITICAL CARE 33..3(2020):732-739